OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of Pharmacogenomics in Individualizing Treatment for Alzheimer’s Disease
Natalie Argueta, Emily Notari, Kinga Szigeti
CNS Drugs (2022) Vol. 36, Iss. 4, pp. 365-376
Closed Access | Times Cited: 13
Natalie Argueta, Emily Notari, Kinga Szigeti
CNS Drugs (2022) Vol. 36, Iss. 4, pp. 365-376
Closed Access | Times Cited: 13
Showing 13 citing articles:
Selenization of Small Molecule Drugs: A New Player on the Board
Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7759-7787
Closed Access | Times Cited: 21
Cristina Morán-Serradilla, Daniel Plano, Carmen Sanmartín, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7759-7787
Closed Access | Times Cited: 21
Xixin Decoction’s novel mechanism for alleviating Alzheimer’s disease cognitive dysfunction by modulating amyloid-β transport across the blood–brain barrier to reduce neuroinflammation
Chuanbin Yang, En-Long Zhao, Hu Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Chuanbin Yang, En-Long Zhao, Hu Zhang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
A review of neuroimaging-based data-driven approach for Alzheimer’s disease heterogeneity analysis
Lingyu Liu, Shen Sun, Wenjie Kang, et al.
Reviews in the Neurosciences (2023) Vol. 35, Iss. 2, pp. 121-139
Closed Access | Times Cited: 8
Lingyu Liu, Shen Sun, Wenjie Kang, et al.
Reviews in the Neurosciences (2023) Vol. 35, Iss. 2, pp. 121-139
Closed Access | Times Cited: 8
Handgrip Strength Is Related to Hippocampal and Lobar Brain Volumes in a Cohort of Cognitively Impaired Older Adults with Confirmed Amyloid Burden
Somayeh Meysami, Cyrus A. Raji, Ryan M. Glatt, et al.
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 3, pp. 999-1006
Open Access | Times Cited: 14
Somayeh Meysami, Cyrus A. Raji, Ryan M. Glatt, et al.
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 3, pp. 999-1006
Open Access | Times Cited: 14
Structurally diverse steroids from an endophyte of Aspergillus tennesseensis 1022LEF attenuates LPS-induced inflammatory response through the cholinergic anti-inflammatory pathway
Jun‐Cheng Su, Qianrong Pan, Xing-Yuan Xu, et al.
Chemico-Biological Interactions (2022) Vol. 362, pp. 109998-109998
Closed Access | Times Cited: 11
Jun‐Cheng Su, Qianrong Pan, Xing-Yuan Xu, et al.
Chemico-Biological Interactions (2022) Vol. 362, pp. 109998-109998
Closed Access | Times Cited: 11
Iron metabolism: An emerging therapeutic target underlying the anti-Alzheimer's disease effect of ginseng
Nan Li, Yuhan Duan, Lei Chen, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 79, pp. 127252-127252
Closed Access | Times Cited: 5
Nan Li, Yuhan Duan, Lei Chen, et al.
Journal of Trace Elements in Medicine and Biology (2023) Vol. 79, pp. 127252-127252
Closed Access | Times Cited: 5
Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis
M H.El sheikh, Mohammad Ammar
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
M H.El sheikh, Mohammad Ammar
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Therapeutic Options in Alzheimer’s Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
Ramón Cacabelos, Olaia Martínez-Iglesias, Natalia Cacabelos, et al.
Life (2024) Vol. 14, Iss. 12, pp. 1555-1555
Open Access | Times Cited: 1
The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu, et al.
(2023), pp. 351-376
Closed Access | Times Cited: 2
Sukriti Vishwas, Monica Gulati, Molakpogu Ravindra Babu, et al.
(2023), pp. 351-376
Closed Access | Times Cited: 2
Alteraciones genéticas asociadas a enfermedad de Parkinson y Alzheimer: evolución y respuesta al tratamiento
Rodrigo Antonio Quezada Rivera, F. Rodríguez, Marcela Romero, et al.
ALERTA Revista Científica del Instituto Nacional de Salud (2024) Vol. 7, Iss. 1, pp. 79-87
Open Access
Rodrigo Antonio Quezada Rivera, F. Rodríguez, Marcela Romero, et al.
ALERTA Revista Científica del Instituto Nacional de Salud (2024) Vol. 7, Iss. 1, pp. 79-87
Open Access
Trends of Pharmacogenomics in Personalized Medicine
John J. Georrge, Saurav Kumar Mishra, Sneha Roy, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 247-276
Closed Access
John J. Georrge, Saurav Kumar Mishra, Sneha Roy, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 247-276
Closed Access
Pharmacogenomic Approaches in Alzheimer's Disease: A Comprehensive Review
Ramdas Bhat, Varshini Varshini, Himasvi Himasvi, et al.
International Journal of Pharmaceutical and Phytopharmacological Research (2023) Vol. 13, Iss. 4, pp. 7-13
Open Access | Times Cited: 1
Ramdas Bhat, Varshini Varshini, Himasvi Himasvi, et al.
International Journal of Pharmaceutical and Phytopharmacological Research (2023) Vol. 13, Iss. 4, pp. 7-13
Open Access | Times Cited: 1
Anti-amyloid Monoclonal Antibodies in Alzheimer’s Disease: A New Hope
Aygun Nasibova, Rovshan Khalilov, Aziz Eftekhari
International Journal of Aging (2023) Vol. 1, pp. e21-e21
Open Access
Aygun Nasibova, Rovshan Khalilov, Aziz Eftekhari
International Journal of Aging (2023) Vol. 1, pp. e21-e21
Open Access
